CPQA works with laboratories participating in HIV clinical trials to improve the quality of pharmacology data, increase awareness of the importance of pharmacology at clinical sites, and provide a mechanism for ensuring the quality of pharmacology data in HIV clinical trials.

The goal of the EQAPOL is to establish a panel of fully characterized viruses from acute/early and chronic HIV infections. Viral Diversity samples are available to NIAID-approved laboratories, and products created for the EQAPOL Viral Diversity Program are available to order.

SMILE assists 167 international laboratories in 22 countries that are performing NIAID-sponsored HIV/AIDS related research, providing expert assistance with patient-safety testing for these clinical trials.

The VQA provides quality assurance support to all laboratories performing virology assays for DAIDS protocols.

**NEW**

**NEW**